CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway

Yang Yang1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;2 Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People’s Republic of China;4 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaView further author information

Mengmeng Zhang1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaView further author information

Fenglin Cai6 Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, People’s Republic of ChinaView further author information

Gang Ma1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaView further author information

Ru-Peng Zhang1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaView further author information

Yiqing Yin2 Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;4 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Jingyu Deng1 Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, People’s Republic of China;5 Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date